{"id":183651,"date":"2020-06-08T15:54:17","date_gmt":"2020-06-08T15:54:17","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=183651"},"modified":"2020-06-08T15:54:17","modified_gmt":"2020-06-08T15:54:17","slug":"un-nou-gigant-se-contureaza-la-orizont-astrazeneca-discuta-despre-o-fuziune-cu-gilead-sciences-in-ceea-ce-ar-putea-fi-cea-mai-mare-tranzactie-din-istoria-industriei-farmaceutice","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=183651","title":{"rendered":"Un nou gigant se contureaz\u0103 la orizont: AstraZeneca discut\u0103 despre o fuziune cu Gilead Sciences, \u00een ceea ce ar putea fi cea mai mare tranzac\u0163ie din istoria industriei farmaceutice"},"content":{"rendered":"<p>\nGigantul farmaceutic britanic AstraZeneca a contactat rivala Gilead Sciences \u00een leg\u0103tur\u0103 cu o posibil\u0103 fuziune a celor dou\u0103 companii care lupt\u0103 \u00eempotriva pandemiei de COVID-19, conform Bloomberg.<\/p>\n<p>\nAstraZeneca, evaluat\u0103 la 140 de miliarde de dolari, dezvolt\u0103 tratemente pentru cancer \u015fi boli cardiovasculare, fiind cel mai mare produc\u0103tor britanic de medicamente dup\u0103 capitalizarea de pia\u0163\u0103. Gilead, evaluat\u0103 la 96 de miliarde de dolari, este creatorul medicamentului care a primit aprobarea Statelor Unite pentru tratarea pacien\u0163ilor infecta\u0163i cu coronavirus.<\/p>\n<p>\nMomentan, Gilead va prefera cel mai probabil s\u0103 se concentreze pe achizi\u0163ii mai mici \u015fi parteneriate, potrivit surselor citate de Bloomberg. \u00cen plus, un purt\u0103tor de cuv\u00e2nt din cadrul AstraZeneca a declarat c\u0103 firma nu comenteaz\u0103 \u201ezvonuri sau specula\u0163ii\u201d.<\/p>\n<p>\nTotu\u015fi, dac\u0103 tranzac\u0163ia se va materializa, ar deveni cea mai mare achizi\u0163ie din istoria industriei farmaceutice. Ac\u0163iunile din cadrul AstraZeneca au crescut cu 41% \u00een ultimele 12 luni, compania devenind astfel cel mai bun performer din indexul Bloomberg pentru companii farmaceutice. \u00cen aceea\u015fi perioad\u0103, ac\u0163iunile Gilead au crescut cu 19%.<\/p>\n<p>\nGilead a atras investi\u0163ii dup\u0103 ce medicamentul antiviral pentru COVID-19, Remdesivir, a trecut testele clinice. Tratamentul, care a primit autorizare din partea Administra\u0163iei pentru Alimente \u015fi Medicamente din SUA, accelereaz\u0103 recuperarea pacien\u0163ilor care au forme avansate de COVID-19.<\/p>\n<p>\n\u00cen urm\u0103 cu dou\u0103 s\u0103pt\u0103m\u00e2ni, AstraZeneca a primit o finan\u0163are de 1 miliard de dolari din partea Autorit\u0103\u0163ii de Cercetare \u015fi Dezvoltare Biomedical\u0103 Avansat\u0103 (BARDA) din Statele Unite pentru a dezvolta un vaccin de combatere a coronavirusului \u00een colaborare cu Universitatea Oxford.<\/p>\n<p>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gigantul farmaceutic britanic AstraZeneca a contactat rivala Gilead Sciences \u00een leg\u0103tur\u0103 cu o posibil\u0103 fuziune a celor dou\u0103 companii care lupt\u0103 \u00eempotriva pandemiei de COVID-19, conform Bloomberg. AstraZeneca, evaluat\u0103 la 140 de miliarde de dolari, dezvolt\u0103 tratemente pentru cancer \u015fi boli cardiovasculare, fiind cel mai mare produc\u0103tor britanic de medicamente dup\u0103 capitalizarea de pia\u0163\u0103. Gilead, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[81,246,30016,474,242,323],"class_list":["post-183651","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-afaceri","tag-crestere","tag-gigant","tag-industrie","tag-istorie","tag-medicamente"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/183651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=183651"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/183651\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=183651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=183651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=183651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}